MM&M is a pharmaceutical marketing media company that produces online and print news for leaders and thinkers in pharma, medical device, diagnostics, and greater healthcare marketing fields.
First published in 1966 as Medical Marketing & Media, every July the magazine produces a list of the top 100 healthcare marketing agencies in North America. This year’s edition features full profiles of each of the Top 100 agencies; an agency family tree, a forum with health network leaders and a report on the new breed of health networks, see full list here.
We are thrilled to announce that Ashfield Healthcare Communications and three of our agencies, Cambridge BioMarketing, Create NYC and MicroMass have been included in the list for 2019.
Cambridge BioMarketing selected as an MM&M Agency 100
We are excited to announce that our agency Cambridge BioMarketing has also been listed in the MM&M Agency 100 listing. We acquired Cambridge BioMarketing two years ago and have watched their success, including their work within rare disease space, such as their brilliant campaigns surrounding Rare Disease Day and their Rare in Common podcast.
Cambridge BioMarketing is a one-of-a-kind agency, aiming to improve the lives of 400 million people affected by rare diseases. With the potential to change lives, their unique approach, RareIDSM uses proven predictive model-matching applications and journey-mapping techniques customised for the rare disease market, enabling clients to confidently understand how to best reach their customers. Click here to find out more about Cambridge BioMarketing.
Create NYC selected as an MM&M Agency 100
We acquired Create NYC to the agency family last July and it has been a great year collaborating with a hugely successful agency. To add to this success they have been named an MM&M agency 100 for the 5th consecutive year!
Create NYC is a different kind of advertising agency they are purpose-built to efficiently execute core healthcare tactics on demand. Create NYC thrive in getting tactics done with immediacy, creativity, and efficiency—all for flat-fee per deliverable pricing. With years of experience as a valued, strategic execution partner with a model to support work as a complement or sole agency, Create NYC are a leading agency within the industry. Find out more about their capabilities here.
MicroMass Selected as an MM&M Agency 100
For the 13th year in a row, MicroMass has been featured in MM&M’s Top 100 Agency Issue. MicroMass has been recognised throughout the year for their amazing, influential and current work within the industry with various industry recognition and award wins including Eye for Pharma Most Valuable Patient Initiative finalist, Digital Health Award winner, eHealthcare Leadership Award winner, and DTC Perspectives winner. We are extremely happy to have MicroMass as part of our agency family and are delighted that they have also been named in the Agency 100.
MicroMass designs solutions across all therapeutic areas that improve patient and health outcomes by changing patient and provider behaviour. These solutions are customised to meet the individual needs of each MicroMass client. Find out more about MicroMass here.